unknown
Stage
1
Investors
About
EnzyTag technology Our technology offers an entry into linear and cyclic peptide drugs, small proteins, (bio)conjugates, Antibody Drug Conjugates, PROTACs and LYTACs.
Explore EnzyTag's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.